IEX Q1 2026: HST Orders Up 17%, Extending Backlog Visibility Into 2027
IDEX’s HST segment delivered standout 17% organic order growth, fueling an expanding backlog and improved multi-year visibility. Management raised full-year guidance as secular strength in data center, semiconductor, and space and defense markets offset pockets of industrial uncertainty. Strategic portfolio focus and bolt-on M&A continue to reshape IDEX’s growth and margin trajectory.
Summary
- HST Backlog Expansion: Robust order growth in Health and Science Technologies underpins improved long-term demand visibility.
- Portfolio Focus Intensifies: IDEX’s 80-20 strategy sharpens resource allocation toward high-value, durable growth markets.
- Guidance Raised: Upgraded outlook leverages secular tailwinds and operational discipline, but maintains conservative modeling for industrial segments.
Performance Analysis
IDEX posted organic sales growth of 5% and adjusted EBITDA margin expansion of 50 basis points, with outperformance concentrated in the Health and Science Technologies (HST) segment. HST delivered 11% organic revenue growth and 17% organic order growth, reflecting secular demand in data centers, semiconductors, and space and defense. These markets, which IDEX defines as “advantage markets,” now form the backbone of the company’s growth narrative and backlog visibility.
The Fluid and Metering Technologies (FMT) segment saw 2% organic sales growth and 9% order growth, led by municipal water and mining, though industrial and chemical end markets remained mixed. Fire and Safety/Diversified Products (FSDP) posted a 1% sales decline, with strength in fire and rescue tools offset by softness in dispensing. Gross margin declined 40 basis points due to mix, but productivity gains and positive price-cost offset these headwinds at the EBITDA level.
- HST Margin Expansion: HST’s adjusted EBITDA margin improved by 100 basis points, driven by volume leverage and productivity, despite ongoing mix drag from acquisitions.
- Order Momentum: Total company organic orders rose 10%, with HST and FMT outpacing FSDP, which declined 4%.
- Cash Flow Dynamics: Free cash flow was seasonally soft at $86 million, reflecting higher working capital tied to growth, but management reaffirmed full-year 100% conversion expectations.
Overall, IDEX’s Q1 performance was characterized by secular strength and backlog build in HST, modest improvement in industrial indicators, and disciplined execution on margin and capital deployment.
Executive Commentary
"Strength was most pronounced in our health and science technologies, or HST segment, where secular drivers continue to fuel growth across high-value applications in data center, semiconductor, and space and defense markets. The strong backlog build in HST improves our visibility to deliver continued solid growth for the balance of the year and into 2027."
Eric Ashleman, President and Chief Executive Officer
"Organic revenue growth of 5% was better than we forecasted, with notable strength in HST. Adjusted EBITDA margin expanded 50 basis points year over year on productivity improvements, positive volume leverage, and positive price cost, partially offset by mix."
Sean Gillen, Chief Financial Officer
Strategic Positioning
1. HST as the Growth Engine
The HST segment, now consistently delivering double-digit order and revenue growth, is the centerpiece of IDEX’s strategic pivot. Backlog expansion and customer co-engineering in data center, semiconductor, and space and defense applications provide rare multi-year demand visibility. Management highlighted that “many of their wins have long multi-year tails that point to really nice growth over time.”
2. 80-20 Strategy Refined
IDEX’s 80-20 methodology, which focuses resources on the highest-value customers and markets, is now being deployed not just for margin improvement but as a deliberate growth tool. By doubling down on fewer, higher-potential customers and platforms, IDEX is creating a flywheel effect that compounds growth and margin expansion.
3. Portfolio Simplification and Capital Allocation
Active portfolio management has allowed IDEX to reallocate capital and talent toward secular growth areas, while pruning lower-value or lower-margin activities. The company maintains a balanced approach: organic investment, bolt-on M&A, and steady capital return via buybacks and dividends. The $76 million in Q1 share repurchases is expected to continue quarterly through 2026.
4. M&A Integration and Moat Building
Recent acquisitions (such as Muon and Mott) have taken time to ramp but are now contributing to growth in core markets. Management views the slow initial uptake as a competitive moat, citing the “defensibility of people that are super risk-averse” and the value of trusted partnerships in mission-critical applications.
5. Industrial and Water Platform Resilience
In FMT, municipal water and mining exposures are providing stability and incremental growth, with high-purity water for semiconductors reversing from a headwind to a tailwind. However, chemical and core energy exposures remain fragmented and subject to short-cycle volatility.
Key Considerations
IDEX’s Q1 demonstrates the company’s secular shift toward high-visibility, high-value markets, but also exposes the uneven recovery in legacy industrial segments. The strategic context is one of disciplined portfolio focus, operational integration, and selective capital deployment.
Key Considerations:
- Secular Demand Tailwinds: Growth in data center, semiconductor, and space and defense is driving outsized performance and backlog in HST.
- Margin Leverage from Acquisitions: Margin expansion in HST depends on raising acquired business profitability through 80-20 actions and mix improvement.
- Industrial Uncertainty: FMT and FSDP order trends improved sequentially, but management maintains a flat outlook due to macro and geopolitical caution.
- Balanced Capital Deployment: Ongoing share repurchases and bolt-on M&A are supported by strong liquidity and cash flow discipline.
- Operational Agility: The component-oriented business model enables rapid reallocation of capital and talent as demand shifts across markets.
Risks
IDEX faces ongoing risks from macroeconomic and geopolitical volatility, particularly in short-cycle industrial and chemical end markets. Margin expansion in HST is contingent on successful integration and margin lift of acquired businesses, while any slowdown in secular growth markets could pressure both backlog and visibility. Tariff and cost inflation remain watchpoints, though management expects limited net impact from current policies.
Forward Outlook
For Q2 2026, IDEX guided to:
- Organic growth of 3 to 4%
- Adjusted EBITDA margin of 26.5% to 27%
- Adjusted EPS of $2.07 to $2.12
For full-year 2026, management raised guidance:
- Organic growth of 3 to 4% (from 1 to 2%)
- Adjusted EBITDA margin unchanged at 26.5% to 27%
- Adjusted EPS of $8.35 to $8.55 (up 20 cents)
Management cited HST backlog and secular demand as key drivers, while maintaining conservative assumptions for FMT and FSDP due to industrial uncertainty and geopolitical risk. No incremental price increases are currently planned, but pricing actions remain a lever if cost pressures reemerge.
Takeaways
IDEX’s Q1 results reinforce the company’s transformation into a secular growth and high-visibility backlog story, with HST now the dominant driver of both momentum and guidance upgrades.
- HST Backlog Visibility: Multi-year demand signals in data center, semi, and defense create a rare growth runway and margin expansion opportunity.
- Portfolio Discipline: 80-20 focus and M&A integration are sharpening both operational execution and capital allocation.
- Industrial Watchpoints: Investors should monitor for inflection in FMT and FSDP as macro and geopolitical uncertainty persists, and track the pace of margin improvement in acquired businesses.
Conclusion
IDEX’s Q1 2026 marks a clear inflection in backlog-driven visibility and secular growth, led by HST’s outperformance. While industrial recovery remains uneven, the company’s disciplined portfolio focus and operational agility position it to capitalize on durable market trends and margin expansion opportunities.
Industry Read-Through
IDEX’s results highlight the accelerating divergence between secular growth platforms and legacy industrial exposures in the diversified industrials sector. Data center, semiconductor, and space and defense demand are driving backlog visibility and premium valuation for suppliers with critical components and systems. Water infrastructure and high-purity applications are emerging as resilient growth vectors, while chemical and traditional industrial markets remain susceptible to macro and geopolitical volatility. Peers with similar portfolio pivots and disciplined capital allocation are likely to outperform in the current environment.